wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q50191687-A8D082D7-4FB5-4D55-B1F9-278CC2201DE3
Q50191687-A8D082D7-4FB5-4D55-B1F9-278CC2201DE3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50191687-A8D082D7-4FB5-4D55-B1F9-278CC2201DE3
Long-term survival and immunological parameters in metastatic melanoma patients who responded to ipilimumab 10 mg/kg within an expanded access programme.
P2860
Q50191687-A8D082D7-4FB5-4D55-B1F9-278CC2201DE3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50191687-A8D082D7-4FB5-4D55-B1F9-278CC2201DE3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2a40e097fed476ca6147bfcb0861c5b51ee83e19
P2860
Ipilimumab in pretreated patients with metastatic uveal melanoma: safety and clinical efficacy.